MGTX
Price
$8.27
Change
+$0.40 (+5.08%)
Updated
Dec 24 closing price
Capitalization
665.66M
77 days until earnings call
Intraday BUY SELL Signals
PHVS
Price
$25.93
Change
+$0.08 (+0.31%)
Updated
Dec 24 closing price
Capitalization
1.68B
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MGTX vs PHVS

Header iconMGTX vs PHVS Comparison
Open Charts MGTX vs PHVSBanner chart's image
MeiraGTx Holdings
Price$8.27
Change+$0.40 (+5.08%)
Volume$238.7K
Capitalization665.66M
Pharvaris
Price$25.93
Change+$0.08 (+0.31%)
Volume$57.09K
Capitalization1.68B
MGTX vs PHVS Comparison Chart in %
MGTX
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MGTX vs. PHVS commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a StrongBuy and PHVS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (MGTX: $8.27 vs. PHVS: $25.93)
Brand notoriety: MGTX and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 41% vs. PHVS: 15%
Market capitalization -- MGTX: $665.66M vs. PHVS: $1.68B
MGTX [@Biotechnology] is valued at $665.66M. PHVS’s [@Biotechnology] market capitalization is $1.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 1 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 1 green, 4 red.
According to our system of comparison, PHVS is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 5 TA indicator(s) are bullish while PHVS’s TA Score has 6 bullish TA indicator(s).

  • MGTX’s TA Score: 5 bullish, 5 bearish.
  • PHVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than MGTX.

Price Growth

MGTX (@Biotechnology) experienced а +1.97% price change this week, while PHVS (@Biotechnology) price change was +7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

MGTX is expected to report earnings on Mar 12, 2026.

PHVS is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.68B) has a higher market cap than MGTX($666M). MGTX (35.796) and PHVS (35.263) have similar YTD gains . MGTX has higher annual earnings (EBITDA): -143.78M vs. PHVS (-166.91M). PHVS has more cash in the bank: 329M vs. MGTX (14.8M). PHVS has less debt than MGTX: PHVS (579K) vs MGTX (88.1M). MGTX has higher revenues than PHVS: MGTX (27.4M) vs PHVS (0).
MGTXPHVSMGTX / PHVS
Capitalization666M1.68B40%
EBITDA-143.78M-166.91M86%
Gain YTD35.79635.263102%
P/E RatioN/AN/A-
Revenue27.4M0-
Total Cash14.8M329M4%
Total Debt88.1M579K15,216%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGTXPHVS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QASGX29.940.06
+0.20%
Federated Hermes MDT Small Cap Growth A
ASLGX136.900.28
+0.20%
American Century Select R5
BKDEX10.800.01
+0.09%
BlackRock Defensive Advantage EM K
FHKAX53.27N/A
N/A
Fidelity Advisor China Region A
DRISX19.23N/A
N/A
North Square Small Cap Value I

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with IDYA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+5.08%
IDYA - MGTX
48%
Loosely correlated
+0.76%
AURA - MGTX
45%
Loosely correlated
-2.65%
XENE - MGTX
45%
Loosely correlated
+1.06%
RGNX - MGTX
45%
Loosely correlated
+0.77%
NUVL - MGTX
44%
Loosely correlated
+0.89%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with MGTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
+0.31%
MGTX - PHVS
36%
Loosely correlated
+5.08%
BEAM - PHVS
35%
Loosely correlated
+1.33%
INKT - PHVS
34%
Loosely correlated
-1.16%
NUVL - PHVS
34%
Loosely correlated
+0.89%
DSGN - PHVS
33%
Poorly correlated
+1.46%
More